// App-Quantinova.ai

P5-08-18 : Mortality rates associated with clinical and pathological characteristics of hormone receptor positive human epidermal growth factor receptor 2 negative early breast cancer: An analysis of the 2010-2016 surveillance, epidemiology, and end results data

Researchers

Presenter

  • Jacqueline Brown

Principal Investigators

  • Michael W Method

  • David R Nelson

Medical Centers

  • Eli Lilly and Company, Windlesham, United Kingdom

  • Eli Lilly and Company, Indianapolis, IN

Locations

  • United Kingdom

  • United States

Companies

  • EMB Statistical Solu

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Hormone receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved